In addition to the experimental model of acquired lymphedema, we also determined VEGF-C levels and the oxidized (GSSG)-to-reduced (GSH) glutathione ratio in the plasma of patients with secondary lymphedema. The gene discussed is VEGFC; the disease is lymphedema.